-
ABOUT USSSY Group Limited is a large high-tech pharmaceutical enterprise with coordinated development of R&D and industrialization in multiple fields such as new drugs, generic drugs, characteristic APIs
-
INNOVATIONSSY Group Limited has built a relatively perfect scientific research and innovation system with the development mode of “production, learning, research, and application” of multi-disciplinary integration and multi-directional combination.
-
RECRUITIt has established high-level innovation platforms such as engineering laboratory and technology research center jointly with Chinese Academy of Sciences, and now has nearly 400 high-level talents in drug research, analysis and clinical research.
-
SUBSIDIARIESThe company has a diversified business development pattern of R&D, production and export of new drugs, generic drugs, characteristic APIs, advanced finished pharmaceutical products, biological preparations and pharmaceutical packaging materials.
-
CONTACTWe will continue to strengthen innovation-driven development, will vigorously encourage the integration of production and research, strengthen and improve the five domains: new drugs, biological drugs, traditional Chinese medicine, generic drugs and APIs
[Photo News] Shijiazhuang No. 4 Pharmaceutical: Every Single Tablet Embodies Responsibility and Mission
Category:
发布时间：2020-03-05
【概要描述】
Since the onset of the epidemic, Shijiazhuang Sihua Pharmaceutical Co., Ltd. has not only stepped up the production of essential medicines for frontline epidemic control but also established an emergency testing mechanism that conducts on-site testing of clinical emergency drugs upon delivery, thereby ensuring their timely supply.
Since the onset of the pandemic, Shijiazhuang Sihua Pharmaceutical Co., Ltd. has not only stepped up production of epidemic-control medications on the front lines but also established an emergency testing mechanism that enables on-demand testing of clinically urgent drugs as they are delivered, thereby ensuring timely supply. At the same time, the company has implemented stringent quality-risk management, intensified incoming inspections of raw and auxiliary materials and real-time monitoring of finished products, standardized operational procedures and risk controls, and rigorously supervised every stage of the manufacturing process to guarantee product quality.
▲ Quality control personnel at Shijiazhuang Sihua Pharmaceutical Co., Ltd. meticulously inspect each sample before it is loaded into the high-performance liquid chromatograph.
▲ Quality inspection personnel at Shijiazhuang Sihua Pharmaceutical Co., Ltd. rigorously verify test results for product content and related substances, ensuring that every quality inspection report issued is accurate and timely.
▲ Quality control personnel at Shijiazhuang Sihua Pharmaceutical Co., Ltd. are performing standardized operations on a gas chromatograph to detect solvent residues in the antiviral drug arbidol hydrochloride capsules.
▲ Quality inspectors at Shijiazhuang Sihua Pharmaceutical Co., Ltd. are conducting batch-by-batch testing of intravenous infusion products that have just rolled off the production line for export to international markets, ensuring that every bottle meets quality standards before leaving the factory.
Keywords:
Recommended News
Share to
SERVICE HOTLINE
Address: Shimen Building, No. 8 Xingye Street, Shijiazhuang Economic and Technological Development Zone
Tel.: +86-311-67167130
Email: office@sjzsiyao.com
Mobile site
E code
Non-Commercial (Filing) – 2025-0091